MX2020005836A - Controles sinteticos para inmunohistoquimica. - Google Patents
Controles sinteticos para inmunohistoquimica.Info
- Publication number
- MX2020005836A MX2020005836A MX2020005836A MX2020005836A MX2020005836A MX 2020005836 A MX2020005836 A MX 2020005836A MX 2020005836 A MX2020005836 A MX 2020005836A MX 2020005836 A MX2020005836 A MX 2020005836A MX 2020005836 A MX2020005836 A MX 2020005836A
- Authority
- MX
- Mexico
- Prior art keywords
- protein
- carrier protein
- immunohistochemistry
- antigen
- synthetic controls
- Prior art date
Links
- 238000003364 immunohistochemistry Methods 0.000 title abstract 3
- 102000014914 Carrier Proteins Human genes 0.000 abstract 4
- 108010078791 Carrier Proteins Proteins 0.000 abstract 4
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 102000002322 Egg Proteins Human genes 0.000 abstract 2
- 108010000912 Egg Proteins Proteins 0.000 abstract 2
- 239000000499 gel Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 108010039918 Polylysine Proteins 0.000 abstract 1
- 102000007562 Serum Albumin Human genes 0.000 abstract 1
- 108010071390 Serum Albumin Proteins 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920000656 polylysine Polymers 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/36—Embedding or analogous mounting of samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
- G01N2333/765—Serum albumin, e.g. HSA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
- G01N2496/25—Reference solutions for assays of biological material containing added polymers to stabilise biological material against degradation or mantain viscosity or density, e.g. gelatin, polyacrylamides, polyvinyl alcohol
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Confectionery (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
La presente descripción se refiere a controles sintéticos útiles, por ejemplo, para inmunohistoquímica (IHC), así como a kits y métodos de fabricación y el uso relacionado con estos. En algunas modalidades, los controles sintéticos incluyen un gel sólido que comprende un antígeno purificado (por ejemplo, en una cantidad conocida) y una proteína transportadora, tal como una proteína de albúmina (por ejemplo, una proteína de albúmina sérica), una proteína de clara de huevo o una mezcla de proteínas de clara de huevo, gelatina o polilisina. En algunas modalidades, el antígeno purificado está reticulado con la proteína transportadora en el gel sólido de antígeno/proteína transportadora.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762595434P | 2017-12-06 | 2017-12-06 | |
| US201862730422P | 2018-09-12 | 2018-09-12 | |
| PCT/US2018/064012 WO2019113171A1 (en) | 2017-12-06 | 2018-12-05 | Synthetic controls for immunohistochemistry |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020005836A true MX2020005836A (es) | 2020-08-20 |
Family
ID=64746658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020005836A MX2020005836A (es) | 2017-12-06 | 2018-12-05 | Controles sinteticos para inmunohistoquimica. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20200292536A1 (es) |
| EP (2) | EP4027144A1 (es) |
| JP (2) | JP7341140B2 (es) |
| KR (1) | KR20200096939A (es) |
| CN (1) | CN112219119A (es) |
| AU (1) | AU2018378025A1 (es) |
| BR (1) | BR112020011325A2 (es) |
| CA (1) | CA3083599A1 (es) |
| ES (1) | ES2920502T3 (es) |
| HR (1) | HRP20220770T1 (es) |
| IL (2) | IL310910A (es) |
| MX (1) | MX2020005836A (es) |
| PL (1) | PL3721230T3 (es) |
| SI (1) | SI3721230T1 (es) |
| TW (1) | TWI820061B (es) |
| WO (1) | WO2019113171A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113740526B (zh) * | 2021-08-20 | 2024-02-20 | 广西康柏莱科技有限公司 | 一种改性封闭剂及其制备方法 |
| CN113607534B (zh) * | 2021-08-20 | 2022-10-18 | 河南赛诺特生物技术有限公司 | 一种染色方法、试剂盒及应用 |
| CN114557953A (zh) * | 2022-02-22 | 2022-05-31 | 烟台毓璜顶医院 | 一种可自发荧光的血清白蛋白微针的制备方法 |
| WO2024064338A1 (en) | 2022-09-22 | 2024-03-28 | Agilent Technologies, Inc. | Anti-human icos antibodies for use in immunohistochemistry (ihc) protocols and for diagnosing cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8813628D0 (en) * | 1988-06-09 | 1988-07-13 | Shandon Southern Prod | Immunostaining |
| EP0352026A3 (en) * | 1988-07-19 | 1991-02-06 | Ruby Pauline Bonderman | A glass slide useful as a control of standard by having several areas of differing levels or types of analytes, and devices and methods for preparing the same |
| CA2042018A1 (en) * | 1989-09-26 | 1991-03-27 | Hector A. Battifora | Quantitative immunocytochemistry assay |
| AU2002352787A1 (en) | 2001-11-20 | 2003-06-10 | Genentech, Inc. | Cell and tissue arrays and microarrays and methods of use |
| AU2003230852B2 (en) * | 2002-04-11 | 2008-07-10 | Children's Medical Center Corporation | TNP-470 polymer conjugates and use thereof |
| CN1727896B (zh) * | 2005-07-22 | 2016-01-27 | 南京川博生物技术有限公司 | 磷酸化及对应非磷酸化蛋白质多克隆抗体在制备疾病诊断试剂中的应用及其制备方法 |
| US9970932B2 (en) * | 2013-03-15 | 2018-05-15 | Arizona Board Of Regents On Behalf Of Arizona State University | Non-covalent patterned chemical features and use thereof in MALDI-based quality control |
| JP5993967B2 (ja) | 2014-02-20 | 2016-09-21 | 国立大学法人秋田大学 | 細胞内生体分子の検出に用いる標準試料及び細胞内生体分子の検出方法 |
| JP5972412B2 (ja) | 2015-02-05 | 2016-08-17 | 国立大学法人秋田大学 | 培養細胞を用いた標準試料及びその製造方法 |
| CN108593380B (zh) | 2018-04-25 | 2021-05-18 | 复旦大学附属中山医院 | 一种组织芯片量产制作方法 |
-
2018
- 2018-12-05 CN CN201880085378.2A patent/CN112219119A/zh active Pending
- 2018-12-05 JP JP2020530652A patent/JP7341140B2/ja active Active
- 2018-12-05 SI SI201830681T patent/SI3721230T1/sl unknown
- 2018-12-05 WO PCT/US2018/064012 patent/WO2019113171A1/en unknown
- 2018-12-05 PL PL18822568.4T patent/PL3721230T3/pl unknown
- 2018-12-05 CA CA3083599A patent/CA3083599A1/en active Pending
- 2018-12-05 MX MX2020005836A patent/MX2020005836A/es unknown
- 2018-12-05 IL IL310910A patent/IL310910A/en unknown
- 2018-12-05 EP EP22157356.1A patent/EP4027144A1/en active Pending
- 2018-12-05 TW TW107143576A patent/TWI820061B/zh active
- 2018-12-05 HR HRP20220770TT patent/HRP20220770T1/hr unknown
- 2018-12-05 AU AU2018378025A patent/AU2018378025A1/en active Pending
- 2018-12-05 EP EP18822568.4A patent/EP3721230B1/en active Active
- 2018-12-05 ES ES18822568T patent/ES2920502T3/es active Active
- 2018-12-05 KR KR1020207019032A patent/KR20200096939A/ko not_active Application Discontinuation
- 2018-12-05 BR BR112020011325-5A patent/BR112020011325A2/pt unknown
-
2020
- 2020-05-25 IL IL274927A patent/IL274927A/en unknown
- 2020-05-29 US US16/888,252 patent/US20200292536A1/en active Pending
-
2023
- 2023-08-29 JP JP2023138663A patent/JP2023169184A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020011325A2 (pt) | 2020-11-17 |
| ES2920502T3 (es) | 2022-08-04 |
| JP2023169184A (ja) | 2023-11-29 |
| KR20200096939A (ko) | 2020-08-14 |
| EP3721230B1 (en) | 2022-04-06 |
| TWI820061B (zh) | 2023-11-01 |
| JP2021505878A (ja) | 2021-02-18 |
| JP7341140B2 (ja) | 2023-09-08 |
| CA3083599A1 (en) | 2019-06-13 |
| CN112219119A (zh) | 2021-01-12 |
| US20200292536A1 (en) | 2020-09-17 |
| HRP20220770T1 (hr) | 2022-09-16 |
| EP4027144A1 (en) | 2022-07-13 |
| TW201925239A (zh) | 2019-07-01 |
| IL274927A (en) | 2020-07-30 |
| EP3721230A1 (en) | 2020-10-14 |
| PL3721230T3 (pl) | 2022-07-18 |
| SI3721230T1 (sl) | 2022-07-29 |
| IL310910A (en) | 2024-04-01 |
| WO2019113171A1 (en) | 2019-06-13 |
| AU2018378025A1 (en) | 2020-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020005836A (es) | Controles sinteticos para inmunohistoquimica. | |
| EA201690299A1 (ru) | СТАБИЛИЗАЦИЯ Fc-СОДЕРЖАЩИХ ПОЛИПЕПТИДОВ | |
| BR112015017307A2 (pt) | composições de espécies com baixa acidez e métodos para produção e uso das mesmas | |
| WO2019056023A3 (en) | Claudin6 antibodies and methods of treating cancer | |
| BR112013008407A2 (pt) | antígenos de clostridium difficile | |
| MX2022000652A (es) | Anticuerpos contra claudina 18 y metodos de tratamiento del cancer. | |
| MX2023005421A (es) | Composiciones de proteina anti-vegf y metodos para producir la misma. | |
| EA201892325A1 (ru) | Композиции и способы детектирования белков клетки-хозяина | |
| EA201790341A1 (ru) | Анти-ск8 антитела для применения в лечении рака | |
| EA202193222A1 (ru) | Определение характеристик домен-специфических зарядовых вариантов антител | |
| MX2021011330A (es) | Anticuerpos de claudina-6 y conjugados de fármacos. | |
| MX2022003432A (es) | Metodos y composiciones que comprenden un anticuerpo monoclonal antictla4 con proteinas de celulas hospederas reducidas y estabilidad del polisorbato-80 aumentada. | |
| WO2019025865A3 (en) | METHODS AND COMPOSITIONS FOR LIGAND-DIRECTED ANTIBODY DESIGN | |
| BR112023022992A2 (pt) | Anticorpo anti-ctla-4 | |
| AR114992A1 (es) | Controles sintéticos para inmunohistoquímica | |
| EA202091973A1 (ru) | Конструкции слитых белков, содержащие анти-muc1 антитело и il-15 | |
| WO2024026468A3 (en) | Methods and compositions regarding cyclic peptides for use with antibodies and antibody fragments | |
| PL424214A1 (pl) | Test diagnostyczny do wykrywania zakażeń i/lub nosicielstwa Streptococcus agalactiae wykorzystujący wyselekcjonowane markery polipeptydowe | |
| DE602005022361D1 (de) | Verfahren zur schädigung von zellen mit effektorfunktionen von anti-gfra1-antikörpern | |
| EA202092928A1 (ru) | Dll3-cd3 биспецифические антитела | |
| EA202191292A1 (ru) | Способы и композиции для иммунотерапии рака | |
| MX2021002573A (es) | Sistemas y procedimientos para electroforesis capilar de afinidad. | |
| AR116502A1 (es) | PROTEÍNAS DE FIJACIÓN A SIRPa Y MÉTODOS DE USO DE ESTAS | |
| WO2018208121A3 (ko) | Mrs에 특이적으로 결합하는 모노클로날 항체 | |
| ATE527354T1 (de) | Diabetogene epitope |